Pharmaceutical

AbbVie’s Q2 2024 net earnings drop to $1.37bn

AbbVie has reported a 32.1% decrease in net earnings attributable to the company of $1.37bn in Q2 2024 from $2.02bn in Q2 last year.

Jul 28, 2024 - 04:00
AbbVie’s Q2 2024 net earnings drop to $1.37bn
AbbVie has reported a 32.1% decrease in net earnings attributable to the company of $1.37bn in Q2 2024 from $2.02bn in Q2 last year.
Read the original article

Tags:

Previous Article

Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn

Next Article

EC conditionally approves Pfizer’s haemophilia B gene therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Cano Health’s downfall offers a warning for Medicare Advantage

STAT+: Cano Health’s downfall offers a warning for Medi...

Feb 5, 2024

Which biotechs need to find a new bank after the collapse of Silicon Valley Bank?

Which biotechs need to find a new bank after the collap...

Mar 19, 2023

FDA lifts clinical hold on PepGen’s myotonic dystrophy type 1 candidate

FDA lifts clinical hold on PepGen’s myotonic dystrophy ...

Oct 13, 2023